ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions
View by Date
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • C1 Esterase Inhibitor (C1INH) Treatment at Kidney Transplant Improves Long-Term Outcomes in Patients at Risk for Ischemia/Reperfusion Injury & Delayed Graft Function

    S. Jordan1, E. Huang2, N. Ammerman1, J. Choi1, O. Aubert3, S. Kumar1, A. Loupy4, A. Peng1, I. Kim1, R. Najjar1, D. Puliyanda1, T. Brennan1, S. Sethi1, A. Vo1

  • C1q Dominant Deposits in Renal Transplant Biopsies Are Not Associated with Allograft Dysfunction

    A. Babu1, S. Williamson2, N. Khoury1, M. Safwan1, A. Patel1

  • C4d Positivity in Renal Biopsies Following A2 to B Kidney Transplantation: Not All A B O Incompatibilities Are Equal

    S. Radomski1, G. Vranic2, B. Thomas2, P. Abrams2, M. Cooper2, A. Gilbert2

  • Calcineurin Inhibitor Holiday for Management of Post Transplant Acute Kidney Injury

    S. Sriperumbuduri, D. Lazarus, T. Fairhead, S. Hoar, J. Karpinski, G. Knoll

  • Calcineurin Inhibitors and Long-Term Outcomes of Kidney Transplantation from Thai Transplant Registry

    S. Udomkarnjananun, N. Townamchai, Y. Avihingsanon, K. Praditpornsilpa

  • Can Cardiac Risk Predictor Models Be Trusted in Kidney Transplant Recipients?

    K. L. Hoffman1, R. R. Alloway1, A. Shields2, E. Woodle2, A. Govil1

  • Can Cxcl8 Inhibitor (reparixin) Improve Islet Engraftment And Clinical Outcomes After Islet Allotransplantation? University Of Chicago Preliminary Results From A Phase 3 Multicenter Randomized, Double-blinded, Prospective Study.

    P. Bachul1, K. Golab1, L. Basto1, L. Wang1, M. Tibudan1, J. Golebiewska2, M. Para1, L. Perea1, F. Antic1, J. Fung1, P. Witkowski1

  • Can Financial Incentives Improve Patient Compliance with Optn Live Kidney Donor Follow-Up Policy? Results of a Randomized Controlled Trial

    M. Henderson, M. Waldram, S. DiBrito, A. Thomas, F. Al Ammary, S. Ottman, A. Massie, J. Garonzik Wang, D. Segev

  • Can Imputation of HLA Allele Level Typing Be Used Clinically in a Multiethnic Population?

    R. M. Engen1, A. M. Jedraszko1, A. Tambur2

  • Can National Data Predict Which Older Kidney Donors Are More Likely to Yield Higher eGFR 1-Year Post-Transplant?

    C. A. Custer1, R. J. Carrico1, T. L. Pruett2

  • Candida auris after Liver Transplant

    N. M. Theodoropoulos, R. Ellison, J. S. Daly, A. Bozorgzadeh, D. A. Mack, L. Gibson, S. M. Levitz

  • Capitalizing On Donor Density To Increase Organ Pool – An Analysis Of Urban And Rural Organ Donors

    S. Bakhtiyar, S. Ahmed, J. A. Goss, A. Rana

  • Capturing Stories about Living Kidney Donation Using Storytelling Capture Technology: A Feasibility Assessment

    A. D. Waterman1, C. S. Anderson1, O. N. Ranasinghe1, Y. Cui2, S. Brecher1, W. Balliet3

  • Cardiac Risk Assessment in Kidney Transplant Candidates: Clinical Usefulness of Different Guidelines

    A. Velioglu1, S. Mehdiyev1, H. Arikan1, E. Asicioglu1, A. Cincin2, S. Tuglular1

  • Cardioprotective Effects of Pre-Operative Cyclosporine in Patients Undergoing Heart Transplantation

    Y. Hirase, M. Harris, M. Watson, H. Lee, C. Patel

  • Cardiovascular Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

    M. Wyld1, N. De La Mata2, P. Masson3, E. O'Lone2, A. Webster2

  • Care of International Living Kidney Donor Candidates in the U.S.: A Survey of Contemporary Experience, Practice & Challenges

    K. Lentine1, M. Henderson2, S. Rasmussen2, E. Shukhman3, J. Hunt4, F. Al Ammary2, V. Kumar5, D. Lapointe-Rudow4, H. Schaefer6, M. Cooper7, R. Hays8, M. Dunbar-Forrest9, A. Nishio-Lucar10, D. Mandelbrot8

  • Caregiving before Thoracic Transplantation–A Qualitative Inquiry

    C. C. Kennedy1, J. Ridgeway1, E. Stevens1, J. Kirsch2, K. Carroll1, J. Griffin1, R. Benzo1

  • Caregiving in Thoracic Transplantation–A SR/MA

    A. A. Rmilah, J. Lau, R. Mendpara, P. Erwin, C. C. Kennedy

  • Case Series Of Total Laparoscopic-hand Assisted Living Donor Right Hepatectomy: First 19 Cases At A Single Center In Usa

    P. N. Martins1, B. Movahedi2, D. Litwin2, A. Bozorgzadeh2

  • Case Series: Anti-Thymocyte Globulin as a Treatment for Steroid-Refractory Severe Acute Hepatitis in Children

    A. L. Peters, A. Miethke, K. Campbell

  • Causes of 30 Day Graft Loss among Shared Kidneys in the National Kidney Registry (NKR)

    J. Verbesey1, A. Thomas2, M. Ronin3, D. Segev4, A. Waterman5, S. Flechner6, M. Cooper1

  • CCR5-Mediated Recruitment of NK Cells to the Kidney is a Critical Step for Host Defense to Candida albicans Infection

    H. R. Cho1, V. G. Tran2, N. N. Nguyen3, S. Lee4, S. W. Kang4, J. Kim4, H. J. Kim4, S. J. Park1, J. S. Lee5, B. Kwon6

  • CD19+ Cell Behavior in the 12 Months Following a Single Dose of Rituximab in Patients with Humoral Rejection: Clinical and Histological Outcomes

    L. Marino, I. A. Martínez-Juárez, J. R. Marino-Sánchez, J. I. Santander-Velez, F. Zamora, H. Juarez, R. Vazquez, L. Llorente, G. Lima, A. Cohen-Bucay, L. E. Morales-Buenrostro

  • CD38 Inhibition: A Novel Target for Hepatic Ischemia Reperfusion Injury

    C. Akateh1, B. F. Reader1, Y. Lee1, J. Kim1, K. Maynard1, K. W. Washburn1, J. L. Zweier2, B. A. Whitson1, S. M. Black1

  • CD4 T Cell is Essential in an Innate-Immune Driven Ischemia-Reperfusion Injury in Mouse and Human

    S. Kageyama1, K. Kadono1, H. Hirao1, K. Nakamura1, T. Ito2, K. J. Dery1, D. Oncel1, R. A. Sosa3, E. F. Reed3, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec-Weglinski1, Y. Zhai1

  • CD4 T Cell-Derived NGAL Mediates Experimental Acute Kidney Injury

    S. Lee, S. Noel, J. Kurzhagen, M. Sadasivam, A. Hamad, H. Rabb

  • Cd45rb Mediates Cd8+T Cell Persistence In An Allogeneic Heterologous Immune Response

    S. M. Krummey, A. B. Morris, M. L. Ford

  • CD46 Transgene Modification and Thrombosis in Neonatal Porcine Islet Xenotransplantation

    M. Song, K. Samy, Q. Gao, R. P. Davis, F. Leopard, Z. Fitch, C. Bennett, G. R. Devi, B. H. Collins, A. D. Kirk

  • CD47 Blockade Promotes Hepatic Macrophage Polarization toward M1 during Normothermic Machine Perfusion of Discarded Human Livers

    M. Xu1, F. Zhou1, S. Garcia-Aroz1, B. Banan1, W. Yang2, G. Upadhya1, K. Byrnes3, B. Wong1, P. Manning4, Y. Lin1, W. Chapman1

  • CD56+CD57+ Infiltrate is a Predominant Subset of Infiltrating Natural Killer Cell in Renal Transplant Biopsies with Antibody-Mediated Rejection

    H. Jung1, Y. Wee2, J. Kim2, M. Choi2, J. Choi2, H. Kwon2, J. Jung2, S. Kim3, Y. Cho4, Y. Park4, H. Go4, M. Han5, Y. Kim2, D. Han2, S. Shin2

  • CEACAM1 – p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura1, S. Kageyama1, T. Ito1, K. Kadono1, M. Kujawski2, K. J. Dery1, R. A. Sosa1, E. F. Reed1, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec‐Weglinski1

  • Cell Coding Transcriptomic Analysis Of Serial Blood And Biopsy Samples In A Large Cohort Of Kidney Transplant Recipients

    W. Zhang1, Z. Yi1, Z. Sun1, K. Keung2, C. Wei1, C. Xi1, S. Farouk1, M. Menon1, P. Cravedi1, P. O'Connell2, B. Murphy1

  • Cellular And Molecular Characteristics Of Intra-graft Lymphoid Aggregates In Chronic Lung Allograft Dysfunction

    E. Miyamoto1, S. Juvet1, D. Hwang2, S. Keshavjee1, T. Martinu1

  • Cellular Sources of Cytokine Production during Cold Ischemia Induced AKI after Kidney Transplant

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation

    A. Y. Choi1, M. S. Mulvihill2, J. Weber3, H. Lee3, M. Cox2, B. Yerokun2, M. Kuchibhatla3, J. A. Klapper2, M. G. Hartwig2

  • Center-Level Probability of Kidney Transplant Varies Considerably for Waitlisted Patients

    K. L. King1, S. A. Husain1, P. Reese2, J. Schold3, S. Pastan4, S. Mohan1

  • Center-Level Variation in HLA-Incompatible Living Donor Kidney Transplantation Outcomes

    K. Jackson1, J. Long1, K. Covarrubias1, J. Motter1, M. Bowring1, J. Chen1, M. Waldram1, B. Orandi2, N. Desai1, A. Massie1, D. Segev1, J. Garonzik-Wang1

  • Central Role of Graft Resident Memory T Cells in Pathogenesis of GVHD after Bowel Transplantation

    J. Weiner, N. Svetlicky, J. Schmidt, S. Moturi, O. Aguirre, J. Kang, M. Sadat, K. Khan, J. Hawksworth, C. Matsumoto, T. Fishbein, A. Kroemer

  • Ceria-Zirconia Nanoparticles as an Enhanced Antioxidant Attenuates Apoptosis of Human Kidney Proximal Tubular Epithelial Cells in Hypoxia

    S. Yoon1, K. Yoon2, S. Hong3, S. Yun1, W. Hwang1, J. Moon4, J. Lee1, H. Jeon1

  • Challenges to Inpatient Management Post Abdominal Wall Transplant (AWT) – From App’s Perspective

    K. Hattori, D. Sudan, K. Ravindra

  • Change in Estimated Glomerular Filtration Rate and Risk of Allograft Failure in Patients Diagnosed with Active Antibody-Mediated Rejection Following Kidney Transplantation

    W. Irish1, P. Nickerson2, B. Astor3, E. Chong4, C. Wiebe2, F. Moreso5, D. Seron5, M. Crespo5, L. Gache6, A. Djamali3

  • Changes in Body Mass Index and Outcomes after Kidney Transplantation: A Single Centre, Retrospective, Observational Study

    A. Arshad1, J. Hodson2, K. Khalil1, A. Sharif3

  • Changes in Kidney Function Following Live Donor Nephrectomy

    N. N. Lam1, A. Lloyd1, K. L. Lentine2, R. R. Quinn3, B. R. Hemmelgarn3, S. Klarenbach1, A. X. Garg4

  • Changes in Kidney Offer Acceptance for Pediatric Candidates Post-KAS

    M. Bowring, K. Jackson, J. Garonzik-Wang, D. Segev, A. Massie

  • Changes in the Fate of KDPI < 35% Kidneys before and after Implementation of the New Kidney Allocation System

    K. Eng, E. Grodstein, L. Castellanos Reyes, L. Teperman, C. Sethna, P. Singer

  • Changing Education Paradigms: Training Fellows for High Stake Procedures

    T. Rice1, H. Lewis1, M. Cuffy1, L. Ratner2, T. Diwan1

  • Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation

    W. Lim1, E. Au2, A. Krishnan1, G. Wong2

  • Characteristics Associated with Immunosuppressant Adherence after Deceased Donor Kidney Transplant

    A. R. Wilk1, W. S. Cherikh1, J. Maghirang1, E. A. Witt2, H. Kirkham2, S. Boghani2, N. Hira3, G. Pietradoni2, D. K. Klassen1

  • Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation

    S. Rehman1, J. Pryor2, A. Olyaei3, M. Stack1, D. Norman1, J. Lockridge1

  • Characterization of Circulating T-cell Specific Exosomes during Acute Rejection in Murine Heart Transplantation Model

    R. Hu1, V. Korutla1, L. Korutla1, S. Rostami1, A. Habertheuer1, S. Addya2, J. Harmon1, P. Zielinski1, S. Reddy1, A. Freas1, C. Ram1, A. Naji1, P. Vallabhajosyula1

  • Characterization of HLA Antibodies by C3d Assay and IgG Subclasses in Sensitized Kidney Transplant Patients

    A. Casillas-Abundis, J. M. Arreola-Guerra, J. Alberu, M. I. Solis-G, L. Llorente, J. Granados, M. Vilatoba, R. Cruz-Martinez, L. Morales-Buenrostro, A. G. Contreras

  • Characterization Of Increased Risk Donor Post-transplant Viral Surveillance Protocol At A Comprehensive Transplant Center

    J. Dann, W. Ally, S. Pelletier, C. Sifri, A. Agarwal

  • Characterization of Innate Lymphoid Cells in Full Facial and Limb Transplant Recipients

    T. J. Borges1, J. T. O’Malley2, B. Kollar3, B. Pomahac3, S. G. Talbot3, L. V. Riella1

  • Characterization of Intra-Exosomal Cargoes of Circulating Donor Heart Specific Exosomes in Murine Heart Transplantation Model

    J. Harmon, V. Korutla, L. Korutla, R. Hu, S. Rostami, A. Habertheuer, P. Zielinski, A. Freas, C. Ram, A. Naji, M. Davis, P. Vallabhajosyula

  • Characterization Of Microscopic Hematuria Following Renal Transplant

    M. L. McDonald1, T. N. Duong2, N. Datta2, H. A. Gritsch1, S. Bunnapradist2

  • Characterizing the Dominant Phenotype in Kidney Transplant Biopsies: Improving the Prediction of Risk by a Global View of Rejection, Injury, and Atrophy-Fibrosis

    P. F. Halloran and The INTERCOMEX Investigators1, J. Reeve2

  • Chemokine Ligand 14 is a Novel Therapeutic Target in Kidney Fibrosis

    S. Lee1, Y. Kim1, J. Moon1, H. Lee1, S. Han1, J. Lee2, R. Cha3, D. Kim1, C. Lee4, K. Kim5, Y. Kim1, S. Yang6

  • Chimeric Allografts Induced by Stem Cell Mobilizing Agents in a Mouse Model of Kidney Transplantation: Role of CD133 Stem Cells

    J. Zhou, l. Qi, A. Ahmadi, R. Wesson, A. Cameron, J. Burdick, Z. Sun

  • Chloroquine’s Effect on T cell Proliferation

    R. Muschalek1, P. Jindra2, R. Kerman2, M. Kueht2, W. Etheridge2, M. Cusick2

  • Cholecystitis in High-Acuity Patients Undergoing Liver Transplantation: A Five-Year Analysis of Incidence, Causes and Impact

    D. S. Graham, T. Ito, M. M. Lu, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • CHOP Deficiency Attenuated Acute Liver Injury by Promoting Macrophage M2 Polarization via ATG5-Mediated Autophagy Activation

    H. Zhou, R. Liu, Q. Wang, C. Shi, F. Cheng, X. Wang, L. Lu

  • Chronic Changes on Time Zero Living Donor Allograft Biopsy Do Not Portend Future Kidney Function

    A. Agarwal1, A. Sites2, K. L. Brayman1, A. Doyle3, J. Oberholzer1, A. Nishio-Lucar3

  • Chronic Kidney Disease among Liver Transplant Candidates: A Rising Burden and Its Impact on Post-Liver Transplant Outcomes

    G. Cullaro1, E. C. Verna2, B. P. Lee1, J. C. Lai1

  • Chylous Ascites Following Laparoscopic Live Donor Nephrectomy: A New Improved Treatment Paradigm

    L. Dale1, R. Sandoval2, L. E. Ratner2

  • Cidofovir for BK Nephropathy Rescue Treatment: A Single Center Experience

    J. Slatinska1, E. Honsova2, T. Rohal1, A. Slavcev3, P. Hruba4, O. Viklicky1

  • Circulating De Novo Donor Specific Antibodies and Carotid Intima-Media Thickness in Pediatric Kidney Transplant Recipients

    K. Sgambat1, S. Clauss2, A. Moudgil1

  • Circulating Donor Specific Antibody and Biopsy C4d Positivity in Pancreas Rejection Increase the Probability of Earlier Return to Insulin after Rejection

    S. M. Riad1, S. Jackson2, E. B. Finger3, R. Kandaswamy3

  • Circulating Donor T and NK Cells in Lung Transplantation Recipients Are Derived from the Donor Lung Parenchyma and Represent Tissue-Resident Memory Cells

    J. F. Kuehne1, R. Ballmàs Sanz1, A. Hitz1, B. Wiegmann2, K. A. Bläsing1, F. Ius2, A. Knoefel2, I. Tudorache2, M. Avsar2, D. Jonigk3, A. Haverich2, G. Warnecke2, C. Falk1

  • Circulating Exosomes Isolated from Human Lung Transplant Recipients with Respiratory Viral Infections Contain Nucleic Acids Specific to Virus and Can Lead to Activation of Stress Proteins

    S. Bansal, R. Bremner, M. Smith, T. Mohanakumar

  • Circulating Exosomes with Cardiac Self-Antigens (Cardiac Myosin and Vimentin) and De Novo Development of Antibodies to Cardiac Self-Antigens Precedes Chronic Cardiac Allograft Rejection

    R. Ravichandran, Y. Itabashi, W. Liu, T. Mohanakumar

  • Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy

    C. Kuscu1, V. Sai Bontha1, C. Kuscu1, D. Maluf1, A. Bajwa1, J. Eason1, V. Mas1, E. Akalin2

  • Circulating T Follicular Helper Proliferation And Memory B Cell Activation Correlate With Donor Specific Allo-antibody Occurrence And Antibody-mediated Rejection After Kidney Transplantation

    K. Louis1, C. Macedo1, M. Marrari1, B. Ramaswami1, M. Lucas1, B. Elinoff1, M. Yamada1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, C. Lefaucheur2, D. Metes1

  • Clazakizumab (CLZ, Anti-IL-6 Antibody) and Tocilizumab (TCZ, Anti-IL-6 Receptor [r] Antibody) Treatments Differentially Affect IL-6/IL-6R Signaling by Modulating Soluble IL-6R (sIL-6R) and gp130 (sgp130) in Kidney Transplant Patients (KTx Pts) Treated for Chronic Antibody-Mediated Rejection (cABMR)

    B. Shin, S. Ge, A. Petrosyan, N. F. Ammerman, A. A. Vo, S. C. Jordan, M. Toyoda

  • Clazakizumab (CLZ, Anti-IL-6 Monoclonal Antibody) Treatment of Patients (Pts) with Chronic Antibody-Mediated Rejection (cABMR) Reduces Total Immunoglobulin (Ig) and Anti-HLA IgG Antibody Levels

    B. Shin, N. F. Ammerman, A. A. Vo, X. Zhang, S. C. Jordan, M. Toyoda

  • Clazakizumab Acts on Endothelial Cells to Limit Antibody Mediated Damage

    J. Lion1, K. Poussin1, E. Chong2, D. Glotz3, N. A. Mooney1

  • Clazakizumab as an Agent to Reduce Donor Specific HLA Antibodies and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation

    S. C. Jordan1, N. Ammerman1, M. Toyoda2, E. Huang1, C. C. Nast3, A. Peng1, S. Sethi1, R. Najjar1, I. Kim1, K. Lim1, J. Choi1, A. Vo1

  • Clinical and Pathologic Differences between Young and Old Living Donors in Young Kidney Transplant Recipients

    C. Baek, H. Kim, H. Lee, Y. Kim, S. Park

  • Clinical Features and Prognosis of Diffuse Intrahepatic Biliary Stricture in Adult ABO-Incompatible Living Donor Liver Transplantation

    J. Kwon, G. Song, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, H. Cho, I. Jeong, J. Choi, S. Yoo, S. Lee

  • Clinical Features of IgA Nephropathy Recurrence after Kidney Transplantation

    H. HIGUCHI1, K. Hotta2, H. Harada1, Y. Wada1, A. Mitsuke1, D. Iwami2, N. Shinohara2

  • Clinical Impact of Race and Timing of Acute Rejection on Recipients of Kidney Transplant on Early Steroid Withdrawal Protocol

    O. Adebiyi, S. Yaqub, W. Goggins, D. Mishler, T. Taber, A. Sharfuddin

  • Clinical Impact of Spontaenous Portosystemic Shunts on the Short Term Outcome of Liver Transplantation

    E. A. Rodriguez1, R. M. Perez2, N. Zhang3, E. S. Lim3, C. R. Miller4, M. A. Schwartz2, A. J. McGirr4, A. Srinivasan5, W. R. Hewitt5, A. C. Silva4, J. Rakela1, H. E. Vargas1

  • Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population

    B. Valdepenas, J. Benken, E. Benedetti, Z. Hajjiri, A. Lichvar

  • Clinical Implications of Serum Mac-2 Binding Protein in Regular Follow Up after Pediatric Living Donor Liver Transplantation

    T. Ueno1, T. Kodama1, Y. Noguchi1, M. Nomura1, R. Saka1, Y. Takama1, Y. Tazuke1, K. Bessho2, H. Okuyama1

  • Clinical Importance of the Updated Oxford Classification in Allograft IgA Nephropathy

    S. Park1, H. Go2, C. Baek2, J. Jeong1, Y. Kim1, Y. Kim1, Y. Kim2, J. Lee3, S. Min1, J. Ha1, E. Song1, Y. Kim1, S. Park2, K. Moon1, H. Lee1

  • Clinical Outcomes and Risk Factors for Delayed or Slow Graft Function in an Adult, Urban Renal Transplant Population

    K. Tejani, Z. Hajjiri, E. Benedetti, A. Lichvar

  • Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience

    O. Y. Mousa1, K. D. Watt1, J. K. Heimbach2, A. P. Keaveny3, J. E. Eaton1, D. M. Harnois3, B. Taner3, E. J. Carey4, A. A. Moss4, C. B. Rosen5, T. Taner5

  • Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation

    D. Kim

  • Clinical Outcomes of Using mTOR Inhibitors with Reduced Dose of Calcineurin Inhibitors in Lung Transplant Recipients: A Single Center Experience

    M. Frawley1, J. Leedy1, A. James1, A. Salter1, V. Rusanov2

  • Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients

    W. Lee, C. Cheng, T. Wu, Y. Wang, C. Lee, T. Wu, H. Chou, K. Chan

  • Clinical Response to Pathological Finding in Uterus Transplantation

    L. Johannesson, G. Testa

  • Clinical Trial of Allogeneic Islet Transplantation in the Treatment of Diabetes after Renal Transplantation

    W. liang, M. Hu, G. Peng, D. Zhou, C. Zeng, W. Zhou, q. Ye, Z. Wang

  • Clinical Utility of a Pharmacogenomic Testing Tool among Kidney Transplant Recipients

    S. LeCorchick, L. Lindberg, W. Stapley, S. Anand, D. Morris, T. Srinivas

  • Clinical Utility of the Edmonton Symptom Assessment System to Screen for Depression and Anxiety in Kidney Transplant Recipients

    E. Tang, S. Dano, A. Ayub, V. Li, I. Escudero, N. Ullah, N. Edwards, M. Novak, I. Mucsi

  • Clinical, Aging, Morphometric Measures & Adverse Outcomes in Kidney Transplant Recipients

    A. Muzaale1, N. Chu1, H. Ying1, B. Ross2, D. Segev1, M. McAdams-Demarco1

  • Clinicopathologic Assessment of Monoclonal Immunoglobulin (Ig) Associated Renal Disease in the Kidney Allograft

    J. Kamal1, R. J. Crew1, X. Ye2, J. Swanson3, G. Appel1, G. Markowitz4, V. D'Agati4, I. Batal4

  • Clonal Composition And Single-cell Characterization Of T-cell Infiltrates In Cardiac Allograft Vasculopathy

    M. V. Habal1, A. Myung2, H. Yan2, S. Rao2, S. Lin2, S. See2, P. Roy2, R. Shihab2, C. Marboe3, S. Restaino1, A. Han2, M. Givertz4, J. C. Madsen5, L. Addonizio1, M. Farr1, E. Zorn2

  • Clostridium difficile Infection Mimics Intestinal Acute Cellular Rejection in Pediatric Multivisceral Transplant – A Case Series

    D. A. Cheung1, T. Beduschi2, A. Tekin2, G. Selvaggi2, R. M. Vianna2, J. Garcia1

  • Cluster Analysis of Microvascular Inflammation in Indication Biopsies Unveils Distinct Pathological and Immunological Phenotypes with Prognostic Implications

    J. Malheiro1, A. Silva1, S. Santos1, S. Tafulo2, L. Martins1, L. Dias1, A. Castro-Henriques1

  • CMV Risk Status Remains a Relevant Risk Factor for Long-Term Outcomes

    G. Karadkhele, W. Zhang, C. P. Larsen

  • CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R+ Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants

    M. Jarque1, A. Cachero2, E. Garcia-Romero3, L. Lladó2, C. Baliellas2, C. Diez3, E. Melilli4, J. Fabregat2, J. Gonzalez-Costello3, O. Bestard4

  • CNI-Free Therapy with Iscalimab (anti-CD40 mAb) Preserves Allograft Histology Compared to Standard of Care after Kidney Transplantation

    E. Farkash1, A. Naik1, H. Tedesco-Silva2, B. Nashan3, O. Witzke4, M. van den Hoogen5, S. Berger6, D. M. Cibrik7, S. Mulgaonkar8, D. B. Leeser9, R. Alloway10, A. Patel11, J. Pratchke12, C. Sommerer13, A. Wiseman14, A. Van Zuilen15, U. Laessing16, J. Rush16, B. Haraldsson16

  • CNV Screening For End-stage Renal Disease

    C. E. Fishman, B. Chang, A. Shaked, B. J. Keating

  • Cognitive Function & Risk Of Adverse Outcomes In Kidney Transplant Candidates

    N. Chu1, Z. Shi1, H. Ying1, C. Haugen1, S. Norman2, D. Segev1, M. McAdams-DeMarco1

  • Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in De Novo Kidney Transplant Recipients: ER-Tac vs LCPT

    G. Spagnoletti, M. P. Salerno, F. De Gennaro, J. Romagnoli, F. Citterio

  • Combination of Ketoconazole and Tacrolimus Increases the Risk of Kidney Transplant Rejection in African Americans

    M. E. Sharshir, A. Zhang, E. Khan, B. Zhang, S. Giusti, R. Zhang

  • Combined Antithymocyte Globulin (ATG) and Rituximab (RTX) Induction in African American (AA) Kidney Transplant Recipients

    S. J. Patel, S. Kuten, C. Pham, R. Knight, M. Hobeika, D. Nguyen, E. Graviss, S. Yi, T. Eagar, A. Gaber

  • Combined Ischemic and Rapamycin Preconditioning Alleviated Liver Ischemia and Reperfusion Injury by Restoring Autophagy in Old Mice

    Z. Rao, X. Pan, W. Zhong, Z. Ding, H. Zhou, C. Liu

  • Combined Liver and Delayed Kidney Transplantation (CLKT) Enables Similar Patient Survival as Liver Transplantation Alone (LTA): Propensity Score-Based Comparison

    B. Ekser1, C. A. Kubal1, R. S. Mangus1, P. Mihaylov1, J. A. Fridell1, L. R. Timsina1, M. Lacerda2, M. Ghabril2, J. A. Powelson1, W. C. Goggins1

  • Combined Pre-Transplant Anti-Donor T-Cell Sensitization with Single Nucleotid Polimorphisms (SNPs) for CYP3A4 Tacrolimus Metabolism Identifies Kidney Transplant Patients at High Risk of Allograft Rejection

    E. Crespo1, A. Vidal1, A. Sefrin2, P. Fontova1, M. Stein2, H. Volk2, J. Grinyó3, P. Reinke2, N. Lloberas1, O. Bestard3

  • Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis

    H. Sharma, H. Bohorquez, D. Oganesyan, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, J. Seal, D. Sonnier, G. Loss

  • Comparative Analysis of Belatacept and Mycophenolate Monotherapy-Based Regimens for HLA Identical Living Donor Kidney Transplantation

    M. Yamada, K. Meganathan, A. Shields, P. Brailey, S. Tremblay, A. Govil, R. R. Alloway, S. Shah, E. S. Woodle, B. G. Abu Jawdeh

  • Comparative Use of Single mTOR vs Dual mTOR/PI3K Inhibition in Regulatory T Cell Expansion for Clinical Application in Transplantation

    R. Gedaly-Eidelman, F. Marti, L. Turcios, E. Chacon, D. Valvi

  • Comparing Antibody-Mediated Rejection with or without Detectable DSA: Similar Pathology and Similar Poor Prognosis

    G. Einecke1, J. Reeve2, P. F. Halloran3

  • Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression

    J. A. Seaman1, S. G. Westphal2, F. Qiu3, D. Bremers4, D. Florescu5

  • Comparison between Urine and Blood NGAL for Early Prediction of Delayed Graft Function in Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

    Y. Li, Y. Li, L. Yan, H. Wang, X. Wu, J. Tang, L. Wang, Y. Shi

  • Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction

    S. Mietz1, D. Roe2, E. Lushin1, E. Anderson1, C. Hage2

  • Comparison Of Estimating Glomerular Filtration Equations In Living Kidney Donor Candidates Prior To Donation

    S. Hebert1, J. Xu2, H. Ibrahim1

  • Comparison of Functional β-cell Function and Insulin Sensitivity of Functioning Pancreas Transplant According to Pre-Transplant Matsuda’s Index

    S. Shin, Y. Ko, D. Kim, J. Kim, H. Kwon, J. Choi, J. Jung, Y. Kim, D. Han

  • Comparison of Initial Sirolimus (SRL) and Everolimus (EVR) Exposure Patterns in Kidney Transplant Recipients

    C. Rosso Felipe, L. Viana, M. Pontello Cristelli, M. Nakamura, L. Ramagnoli, S. Braga, V. Lima, A. Carnevalle, D. Casarini, J. Medina Pestana, H. Tedesco Silva Junior

  • Comparison of Isolated Transplant Glomerulopathy with Chronic Antibody-Mediated Rejection in Regards to Endothelial-to-Mesenchymal Transition and Graft Survival

    B. H. Ozdemir1, F. N. Ozdemir2, G. Moray3, M. Haberal3

  • Comparison of Long-Term Outcomes between Alemtuzumab and Rabbit Anti-Thymocyte Globulin for Acute Kidney Allograft Rejection

    M. van der Zwan, M. C. Clahsen-van Groningen, D. L. Roelen, M. W. van den Hoogen, M. Van Agteren, J. I. Roodnat, C. C. Baan, D. A. Hesselink

  • Comparison of Minimal Incision Kidney Transplantation with Conventional Incision Kidney Transplantation: Interim Report of a Randomized Controlled Trial

    T. Lin, T. Song, Y. Jiang, Y. Fan, X. Wang, Z. Huang, J. Liu, Z. Wang

  • Comparison of Oral Microbiome in Stable vs Declining Kidney Function in Renal Transplant Recipients

    J. Wu1, A. Muthusamy2, G. Al-Ghalith3, B. Wu4, B. Guo4, W. Guan4, D. Knights3, W. Oetting5, D. Schladt2, R. Remmel5, P. Jacobson5, A. K. Sharma6, A. Matas7, A. Israni1, D. Skaar8

  • Comparison of Planned vs. Unplanned Pregnancies in Female Kidney Transplant Recipients

    S. Rao1, L. A. Coscia2, D. Kliniewski2, S. Constantinescu3, M. J. Moritz4

  • Comparison of Portal vs Systemic Venous Drained Pancreas Transplantation Alone Matched by Propensity Score Analysis

    F. Vistoli, N. Napoli, F. Palumbo, E. Kauffmann, V. Perrone, S. Iacopi, C. Lombardo, G. Amorese, P. Marchetti, U. Boggi

  • Comparison of Pregnancy Outcomes by Conception Age in Female Kidney Transplant Recipients

    S. Rao1, L. A. Coscia2, D. Kliniewski2, S. Constantinescu3, M. J. Moritz4

  • Comparison of Proton Pump Inhibitors versus Histamine-2-Receptor Antagonists on Clostridium difficile Rates in Liver Transplant Recipients

    S. Wiehe, K. Roach, A. Qamar

  • Comparison of Simultaneous Pancreas kidney Transplantation to Kidney Transplantation Alone for Type 2 Diabetes with End Stage Renal Disease

    Y. Fu, Z. Shen

  • Comparison of Tacrolimus or Cyclosporine Combined with Methotrexate for Graft versus Host Disease Prophylaxis after Allogeneic Hematopoietic Cell Transplantation: A Meta-Analysis

    M. Chen, B. Huang, Y. Zhang, W. Ju, X. He

  • Comparison of Two Dosing Regimens of Valganciclovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant Recipients

    A. L. Bixby, L. Fitzgerald, L. Cotiguala, J. M. Park, D. Kaul, C. Sonnenday, S. Tischer

  • Comparison of Two Glucagon-Like-Peptide-1 Analogs (GLP -1) Dulaglutide vs Liraglutide for the Management of Diabetes in Solid Organ Transplant (SOT)

    P. Singh, M. Taufeeq, T. E. Pesavento, K. Washburn, D. Walsh, S. Meng

  • Comparison with Solid Organ Transplants Reveals Distinct Face Transplant Rejection Gene Signature That Reflects the Unique Immunobiology of Skin

    T. Win, B. Dyring-Andersen, R. Lopdrup, J. Teague, N. Murakami, A. Chandraker, S. G. Tullius, B. Pomahac, L. V. Riella, R. A. Clark

  • Compatible Pairs And Non-directed Living Donors Enhance Paired Exchange Kidney Transplantation: Single-center Experience

    L. Jaber, C. Tiletile, J. Bellingham, N. Garg, A. Hassoun, H. Mahanty, N. Neidlinger, A. Sandhu, P. Patel, W. Bry, S. Katznelson, V. Peddi

  • Compatible Pairs in Paired Kidney Exchange – Are There Winners and Loosers?

    V. Chipman1, B. Lee1, M. Cooper2, M. C. Cuffy3, M. Ronin4, G. Hil4, S. Flechner5, A. Thomas6, D. A. Mandelbrot7, A. D. Waterman8, C. E. Freise1, G. R. Roll1

  • Complement Blockade in Kidney Recipients Prevents Delayed Graft Function and Antibody-Mediated Rejection in Non-Human Primates

    M. Eerhart1, J. Reyes1, C. Blanton1, J. Danobeitia1, P. Chlebeck1, L. Zitur1, J. Coonen1, S. Capuano1, A. D’Alessandro1, J. Torrealba2, W. Zhong1, Y. Yankol1, L. Fernandez1

  • Complete Robotic-Assisted Kidney Transplantation: Our Initial Experience

    A. Khan, C. Bhati, T. Reichman, A. Cotterell, D. Kumar, G. Gupta, L. Kamal, A. King, A. Sharma, M. Levy

  • Complex Live Donor Anatomy Does Not Preclude Kidney Transplantation

    P. Veitch, T. Brown, A. Courtney, J. McDaid

  • Complications of Interposition Grafts for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation

    S. Kim, G. Chun, I. Song

  • Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation

    S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen

  • Computational Assessment of T-cell and B-cell Allorecognition to Predict Donor HLA Immunogenicity

    H. C. Copley1, M. Elango1, V. Kosmoliaptsis2

  • Concentric Circles, One Year in: Concentrated Organ Discard and Waitlist Deaths in High Traffic Areas

    R. J. Lynch1, S. Karp2, W. Chapman3

  • Conceptual Extension of SNP Based Abundance Profiling to Infer Donor Derived Cell-Free DNA Fraction as an Indication of Organ Rejection

    R. Sinha, K. Mickey, J. Grantham, M. Wissel, M. Altrich, S. Kleiboeker

  • Consideration for Offering Hepatitis C Antibody Positive Donor Grafts to All Patients Listed for Transplant

    L. Smith

  • Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients

    K. Ostendorf1, N. Memaran1, B. Borchert-Mörlins1, J. von der Born1, E. Bauer1, A. von Wick1, J. Oh2, M. J. Kemper3, R. Büscher4, B. M. Schmidt5, A. Melk1

  • Contemporary Predictors and Impact on Survival of Early Readmission after Kidney Transplant: Analysis of the Nationwide Readmission Database

    N. Elfadawy, N. Tashtish, S. Al-kindi, D. Hricik, E. Sanchez, N. Sarabu

  • Contemporary US Prevalence and Outcomes of Pneumocystis jirovecii Pneumonia and Toxoplasmosis in Pediatric Solid Organ and Hematopoietic Cell Transplantation Recipients

    M. I. Ardura1, J. Stanek2, B. Hanisch3, B. Hanisch4, K. Sprott5, H. Rangarajan6

  • Continuous 24-Hour vs. Daily Antithymocyte Globulin (ATG) Infusions for Treatment of Renal Allograft Rejection: Preliminary Results of a Prospective Trial

    S. J. Patel, S. Kuten, R. Knight, J. Nolte-Fong, D. Nguyen, E. Graviss, A. Gaber

  • Continuous Distribution: LSAM Simulation Study

    T. Weaver1, N. Salkowski1, J. Snyder1, D. Schladt1, J. Pyke1, A. Herreid1, B. Thompson1, W. Kim2, J. Lake3, A. Israni1

  • Contrast-Enhanced Ultrasonography Predicts Insulin Secretion Ability at 1 Year after Pancreas Transplantation

    N. Aida1, T. Kenmochi1, T. Ito1, K. Kurihara1, A. Kawai1, T. Nishikawa2, I. Hiratsuka3, M. Shibata3, A. Suzuki3, M. Hasegawa4, M. Kusaka5, M. Hoshinaga5

  • Contribution of CD38 to Methionine Choline Deficient (MCD) Diet-Induced Liver Injury in Rats

    J. Kim, Y. Lee, B. F. Reader, C. Akateh, K. R. Maynard, K. W. Washburn, J. L. Zweier, B. A. Whitson, S. M. Black

  • Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies

    K. Louis1, D. Viglietti1, D. Pievani1, O. Aubert1, D. Glotz1, C. Legendre1, A. Zeevi2, A. Loupy1, C. Lefaucheur1

  • Conversion from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®): A Real World Cohort Highlighting Dosing Variability among Patients

    K. D. Belfield1, D. Malhotra2, M. Waleed3, E. A. Cohen1

  • Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus

    I. Carrión Barberà, M. C. Fajardo, D. Tsapepas, J. Gartshteyn, A. Askanase, H. E. Fernandez

  • Correlates of Significant Weight Changes Following Pancreas Alone Transplantation

    A. Arunachalam, F. Aziz, N. Garg, M. Mohamed, A. Djamali, J. Odorico, D. Mandelbrot, S. Parajuli

  • Correlates of Surgical Difficulty and Post-Operative Complications in Living Donor Kidney Procurement

    B. I. Shaw1, F. R. Schwartz2, F. Vernucci2, F. Rigiroli2, F. Gonzalez2, R. Lerebours3, A. S. Rege1, D. Vikraman1, D. Marin2, K. V. Ravindra1

  • Correlation between Gene Expression and Cardiac Function in Ex Vivo Perfused Porcine Hearts

    S. Rotich, N. Herbers, S. Hatami, J. Nagendran, M. Mengel, D. Freed, B. Adam

  • Correlation between Gene Expression and Histology in Transbronchial Lung Transplant Biopsies

    B. Adam, K. Du, S. Rotich, M. Mengel

  • Correlation between Self-Reported Medication Adherence and Side Effects in Cardiothoracic Transplant Recipients

    T. Harrison1, N. Patel1, H. Corbo1, K. Foster1, H. Meadows1, N. Pilch1, C. Perez1, J. Fleming1, D. Judge2, L. Paoletti3, D. Taber1

  • Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients

    T. Harrison1, K. Foster1, N. Patel1, H. Meadows1, C. Perez1, H. Corbo1, J. Fleming1, N. Pilch1, D. DuBay2, J. McGillicuddy2, S. Nadig2, V. Rohan2, D. Taber1

  • Correlation of Crossmatch Predictions with Actual Results and Clinical Outcomes

    R. Forbes1, B. Concepcion1, S. Fossey2

  • Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies

    I. Moinuddin1, D. Kumar1, P. Halloran2, L. Kamal1, A. King1, P. Kimball1, M. Levy1, C. Bhati1, D. Massey1, G. Gupta1

  • Correlations between Preoperative Hepatic Venous Pressure Gradient and Graft Hemodynamics after Reperfusion in Living Donor Liver Transplantation

    H. Matsushima, M. Fujiki, K. Sasaki, F. Aucejo, T. Diago Uso, C. Kwon, B. Eghtesad, C. Miller, C. Quintini, K. Hashimoto

  • Cost-Effectiveness Analysis of Renal Replacement Therapy Strategies in Haiti

    J. S. Pyda1, L. James2, J. J. Kim2, K. Khwaja1, M. Shrime3

  • Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

    J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

  • Costimulatory Blockade and Allo-Specific Treg Therapy for Liver Transplant Recipients: Preclinical Data

    L. Contreras-Ruiz1, K. Shimozawa2, R. Zhang1, L. Turka3, J. F. Markmann3, E. C. Guinan2

  • Costs Associated with A2 to B Kidney Transplantation: A Barrier to Its Utilization?

    R. Forbes, B. Concepcion, D. Shaffer

  • Costs In Contemporary Transplant Practice

    M. Wyld, T. Ying, K. Wyburn, S. Chadban

  • Costs of Kidney Recoveries Varies Dramatically across Organ Procurement Organizations

    J. P. Roberts1, J. Bragg-Gresham2, P. J. Held3

  • Could Intravenous Iron Strengthen The Chances Of Heart Transplantation For Patients With Left Ventricular Assist Devices?

    A. Mardis1, C. Mardis2, J. Barham3, A. Poole3, S. Branham3, R. Napier4, J. Martin3, P. McCann4

  • Creating Geographic Catchment Areas for Solid Organ Transplant Centers

    K. Ross1, R. Patzer2, D. Axelrod3

  • Cryopreservation Allows for Extended Graft Survival in a Rat Orthotopic Hind Limb Model

    S. A. Fidder1, B. Oh1, F. Messner1, G. Furtmueller1, K. Helke2, E. Greene3, Z. Chen3, L. Campbell3, G. Brandacher1, K. Brockbank3

  • Cryopreserved Human Iliac Arteries Allografts: Different Thawing Rates Affect on Their Structural Changes and Mechanical Properties

    R. Novotny1, J. Chlupac1, R. Matejka2, T. Marada1, P. Mericka3, L. Sterba3, L. Janousek1, J. Fronek1

  • CURATE.AI: Personalized Liver Transplant Tacrolimus Dosing

    A. Zarrinpar1, T. Kee2, P. Wang3, J. Khong3, U. Kim1, J. Chong2, J. B. Jeong3, A. T. Truong2, S. Tan2, B. K. Betzler2, W. Ng2, C. Ho3, D. Ho2

  • CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients

    A. Q. Terry1, R. A. Sosa1, B. V. Naini1, V. Groysberg1, F. M. Kaldas2, R. W. Busuttil2, D. Gjertson1, J. Kupiec-Weglinski2, E. F. Reed1

  • Cyclo (his-pro) Protects Against Gentamicin Induced Cell Apoptosis And Cisplatin Induced Acute Kidney Injury Through Inhibiting P53 Mediated Apoptotic Pathway.

    Y. Kim1, J. Moon1, J. Jeong1, J. Kim1, S. Lee1, M. Yu2, C. Lee3, Y. Kim1, S. Yang4

  • CYP3A5 Genotype Had No Influence on Renal Function after Renal Transplantation

    J. E. Kimpton, A. J. Hughes, I. MacPhee

  • CyTOF and RNAseq Analyses Unravel Early Phenotypic and Transcriptional Changes in Antibody-Secreting and Memory B Cells >1 Year Prior to Antibody-Mediated Rejection

    C. Fischman1, M. Fribourg1, J. Ansari2, L. Gallon2, F. Ginevri3, P. Comoli4, M. Cioni3, A. Nocera3, M. Bruschi3, C. Cantarelli1, L. Perin5, P. Cravedi1

  • Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute Cellular Compared to Chronic Active Antibody-Mediated Rejection

    N. Borsum, T. Ahlenstiel-Grunow, L. Pape

  • Cytomegalovirus (CMV) Infection Induces an Angiogenic Response through Hepatic Stellate Cells (HSCs) and Leads to Early Post-Transplant Liver Fibrosis (LF) and Poor Graft Survival

    B. H. Ozdemir1, G. Ozgun1, E. H. Ayvazoglu Soy2, N. Haberal1, G. Moray2, M. Haberal2

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences